Clinical Trial: Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Tacrolimus and Mycophenolate Versus Tacrolimus and Sirolimus vs. Neoral and Sirolimus Used in Combination in Cadaver and Non-HLA Identical Living Related Kidney Transplant
Brief Summary: Comparison of outcomes/safety/and tolerability of SRL/FK/Pred vs. FK/MMF/Pred vs. SRL/Neoral®/Pred in cadaveric and non-HLA identical LRD kidney transplants.
Detailed Summary:
Sponsor: University of Miami
Current Primary Outcome: Incidence and severity of acute rejection episodes [ Time Frame: 1 year ]
Original Primary Outcome: Same as current
Current Secondary Outcome: 1. Graft loss 2. Renal function as determined by serum creatinine and calculated creatinine clearance (using the Cockcroft-Gault method) six and 12 months [ Time Frame: 1, 3, and 5 years ]
Original Secondary Outcome: Same as current
Information By: University of Miami
Dates:
Date Received: May 19, 2008
Date Started: May 2000
Date Completion:
Last Updated: May 23, 2008
Last Verified: May 2008